Abstract
Treatment of rats with phenobarbital (PB) caused an increase in microsomal biphenyl 4-hydroxylase activity and urinary glucaric acid excretion. Hepatic microsomal biphenyl 4-hydroxylase activity was correlative with urinary glucaric excretion in PB-treated rats. Hepatic microsomal biphenyl 2-hydroxylase activity was not correlated with urinary glucaric excretion in PB, 3-methylcholanthrene (3-MC)- and beta-naphthoflavone (beta-NF)-treated rats. Pretreatment of rats with carbon tetrachloride caused decreases in urinary glucaric acid excretion and biphenyl 2- and 4-hydroxylase activities. On the other hand, pretreatment with cobalt chloride caused decreases of these enzyme activities, but not of urinary glucaric acid excretion. These findings suggest that the urinary glucaric acid level would not always provide an index for assessment of hepatic drug metabolizing enzyme activity. These findings suggest that the urinary glucaric acid level would not always provide an index for assessment of hepatic drug metabolizing enzyme activity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: European journal of drug metabolism and pharmacokinetics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
